Financials
- Market Capitalization 8.43 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 978 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.95 USD | +0.13% | +0.14% | +1.53% | +106.69% | 9.01 B USD | ||
| 994 | ABVX Abivax SA - American Depositary Shares | 111.73 USD | -1.43% | -5.31% | -7.20% | +39.65% | 8.77 B USD | ||
| 1019 | IBRX ImmunityBio, Inc. - Common Stock | 7.95 USD | -1.24% | +3.38% | +10.72% | +239.74% | 8.43 B USD | ||
| 1020 | APGE Apogee Therapeutics, Inc. - Common Stock | 135.08 USD | +0.08% | +0.17% | +0.72% | +152.06% | 8.40 B USD |